Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BioIVT
BioIVT
Activities:
Research & Development
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
BioIVT acquires supplier of "human biological material" for in vitro
PrecisionMed is a leading supplier of high-quality human biological material for genetics, drug discovery, and biomarker research and in vitro diagnostics
Research & Development
BioIVT acquires Fidelis Research
The transaction increases BioIVT's network and allows it to extends to deliver fresh biospecimens and produce cell products for drug and diagnostic development
Research & Development
BioIVT acquires Cypex, a leading manufacturer of drug-metabolising enzymes
Cypex’s recombinant xenobiotic metabolising enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug research and development
Research & Development
BioIVT appoints Senior VP, Global Commercial Operations
Jennifer Murphy has more than 16 years’ experience in the diagnostics and life sciences industries
Research & Development
BioIVT hosting open house at London blood donor centre
The company’s Wood Lane location has expanded apheresis, whole blood, and plasma collection capabilities, as well as an on-site cell isolation laboratory
BioIVT appoints new COO
Lori Ball will move from her role as President and CEO of LAB Strategies take up the role at the provider of research models and services for drug and diagnostic development
Research & Development
Study uses fresh method to evaluate botanical-drug interactions
A whole cell model using Transporter-certified hepatocytes in sandwich culture has demonstrated that false positives might be a risk with the traditional method of analysis
Subscribe now